Login / Signup

Nano drug delivery systems improve metastatic breast cancer therapy.

Runqi ZhuTianqun LangQi YinYaping Li
Published in: Medical review (Berlin, Germany) (2021)
Despite continual progress in the technologies and regimens for cancer therapy, the treatment outcome of fatal metastatic breast cancer is far from satisfactory. Encouragingly, nanotechnology has emerged as a valuable tool to optimize drug delivery process in cancer therapy via preventing the cargos from degradation, improving the tumor-targeting efficiency, enhancing therapeutic agents' retention in specific sites, and controlling drug release. In the last decade, several mechanisms of suppressing tumor metastasis by functional nano drug delivery systems (NDDSs) have been revealed and a guidance for the rational design of anti-metastasis NDDSs is summarized, which consist of three aspects: optimization of physiochemical properties, tumor microenvironment remodeling, and biomimetic strategies. A series of medicinal functional biomaterials and anti-metastatic breast cancer NDDSs constructed by our team are introduced in this review. It is hoped that better anti-metastasis strategies can be inspired and applied in clinic.
Keyphrases
  • metastatic breast cancer
  • cancer therapy
  • drug delivery
  • drug release
  • signaling pathway
  • single cell
  • quality improvement
  • bone marrow
  • bone regeneration